Faculdade de Medicina da Universidade de Sao PauloSao Paulo, São Paulo, Brazil
Rheumatologist
2546: Anti-infliximab Antibodies as a Marker of Drug Survival and Tapering in Ankylosing Spondylitis Patients: 12 Years Follow-up
Tuesday, November 14, 20234:15 PM – 4:25 PM PT
Disclosure information not submitted.